New gadget aims to sharpen MRI readings for pancreatic cancer

NCT ID NCT04588025

Recruiting now Diagnosis Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a small, portable device called P4 that sits inside an MRI scanner to improve the accuracy of scans for pancreatic cancer. Researchers want to see if it can reduce errors when measuring blood flow in tumors, which helps doctors know if treatment is working. The trial includes 5 healthy volunteers and 50 pancreatic cancer patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Point-of-care Portable Perfusion Phantom (P4) device
What this could lead to: If successful, this device could make MRI scans more reliable for tracking whether pancreatic cancer treatments are working, helping doctors adjust therapy sooner.
What could go wrong: This is a small, early-stage study focused on measurement accuracy, not treatment. The device may not improve outcomes or be adopted widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER

Contacts and locations

Locations

The Ohio State University
RECRUITING

Columbus, Ohio, 43210, United States
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.